Everything you care about in one place
Follow feeds: blogs, news, RSS and more. An effortless way to read and digest content of your choice.
Get Feederfiercebiotech.com
FierceBiotech
Get the latest updates from FierceBiotech directly as they happen.
Follow now 338 followers
Latest posts
Last updated about 23 hours ago
Thermo Fisher sees higher Q1 earnings amid strong biopharma demand
about 23 hours ago
Thermo Fisher Scientific reported “a strong start to the year,” buoyed by...
WCG acquires The Contract Network in bid to streamline clinical trial execution
1 day ago
Clinical trials solutions provider WCG is acquiring tech company The Contract Network...
Compass, Usona score FDA national priority vouchers amid Trump administration’s psychedelic push
1 day ago
The FDA is awarding national priority vouchers to Compass Pathways and the...
After Lilly’s $7B Kelonia deal, are there any in vivo CAR-T biotechs left to buy?
1 day ago
Despite the recent “feeding frenzy,” Pitchbook’s Ben Zercher told Fierce he expects...
Chutes & Ladders—Helus shuffles out CEO after two months, adds experience to science board
1 day ago
Two months after bringing in Michael Cola to man the helm at...
Avalyn aims for $182M IPO to fund phase 3 trials of reformulated respiratory drugs
2 days ago
Avalyn Pharma is hoping to rake in around $181.8 million from an...
Regeneron ushers in new genetic medicine era with groundbreaking gene therapy approval
2 days ago
Travis Smith was a very serious baby. Born completely unable to hear...
Despite data concerns, Roche’s oral SERD can still be largest product in company history: exec
2 days ago
While the scale of the currency headwinds in Roche’s first-quarter financial update...
Pfizer cans work on next-gen conjugate in cancer patients
3 days ago
Pfizer has abandoned work on a PD-L1-targeting drug that was being tested...
Johnson & Johnson teams up with Viz.ai on hematoma detection
3 days ago
Johnson & Johnson is working with artificial intelligence (AI) disease detection and...
Kurma closes €215 Europe-focused fund to spread across 20 biotechs
3 days ago
Kurma Partners has closed its fourth biotech venture capital fund after raising...
From debt to ‘acceptable’ prices: Roche CEO lists 3 reasons for sitting out Big Pharma M&A spree
3 days ago
While Big Pharmas embarked on a frenzy of acquisitions over recent weeks...